UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                           WASHINGTON, DC 20549

                                 FORM 10-Q


(Mark One)

[X]  QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
     OF 1934
               For the quarterly period ended September 30, 2001

[ ]  TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT


                        Commission File Number:  0-27524
-----------------------------------------------------------------------------
                    DYNAMOTIVE ENERGY SYSTEMS CORPORATION
            (Exact name of Registrant as specified in its charter)
-----------------------------------------------------------------------------



                British Columbia                          N/A
         (State or other jurisdiction of           (I.R.S. Employer
           incorporation or organization)         Identification No.)

                       Suite 105 - 1700 West 75th Avenue
                            Vancouver, B.C. V6P 6G2
                   (Address of principal executive offices)

                                (604) 267-6000
                          (Issuer's telephone number)



Check whether the issuer (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the past 12 months (or for
such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days.
Yes [X]No [ ]


State the number of shares outstanding of each of the issuer's classes of
Common Stock, as of the latest practicable date:

            Class                       Outstanding October 31, 2001
      -----------------------------------------------------------------
        Common Stock, no par value        40,192,579












PART I - FINANCIAL INFORMATION

ITEM 1.     FINANCIAL STATEMENTS

    The following financial statements have been prepared in accordance with
accounting principles generally accepted in Canada.  While adhering to these
Canadian accounting principles results in financial statements disclosing an
information content substantially similar to financial statements that comply
with United States generally accepted accounting principles, there are
material variations in the two country's accounting principles, practices and
methods used.  Reference should be made to the notes that accompany the
Company's financial statements as well as to Note 16 of the Company's annual
report on Form 10-K which discuss the material variations in the accounting
principles in Canada as compared to those followed in the United States.


      Interim Financial Statements                            Page

      Consolidated Balance Sheet                               3
      Consolidated Statement of Loss and Deficit               4
      Consolidated Statement of Cashflow                       5
      Notes to Interim Financial Statements	                    6 - 29














             CONSOLIDATED FINANCIAL STATEMENTS (in U.S. dollars)


                    DYNAMOTIVE ENERGY SYSTEMS CORPORATION




                            September 30, 2001



                     DynaMotive Energy Systems Corporation
                         CONSOLIDATED BALANCE SHEET
<TABLE>
<CAPTION>
                                                 (in U.S. dollars)
                                            September 30,      December 31,
                                                2001             2000
                                                  $                $
------------------------------------------------------------------------
<S>                                           <C>            <C>
ASSETS
Current
Cash and cash equivalents                          44,005     1,095,715
Accounts receivable                               266,609       298,676
Government grants receivable [note 5b and 9]      644,653       661,046
Inventory                                          17,120        20,528
Prepaid expenses and deposits                     238,087       136,848
------------------------------------------------------------------------
Total current assets                            1,210,474     2,212,813
------------------------------------------------------------------------
Deferred project costs                          2,913,966            --
Capital assets                                  2,630,813     1,526,369
Goodwill                                          122,956            --
Patents                                           660,016       729,938
------------------------------------------------------------------------
                                                7,538,225     4,469,120
========================================================================

LIABILITIES AND SHAREHOLDERS' EQUITY
Current
Accounts payable and accrued liabilities        1,721,677       560,906
Bank indebtedness -short term [note 3]            305,983       233,520
Deferred Revenue                                   52,429       103,948
Minority interest                                      --            --
------------------------------------------------------------------------
Total current liabilities                       2,080,089       898,374
------------------------------------------------------------------------
Bank Indebtedness - long term [notes 3]         2,015,802            --
Shareholders loan                                 408,779            --
Other loan                                        250,783            --
------------------------------------------------------------------------
Total liabilities                               4,755,453       898,374
------------------------------------------------------------------------
Commitments and contingencies [note 1, 5 and 6]
Shareholders' equity
Share capital, [note 4]                        24,084,098    21,040,882
Shares to be issued                                82,831       250,713
Convertible shareholders loan                     161,082            --
Contributed surplus [note 4f]                   2,151,160     1,584,997
Cumulative translation adjustment                (553,430)     (371,062)
Deficit                                       (23,142,969)  (18,934,784)
------------------------------------------------------------------------
Total shareholders' equity                      2,782,772     3,570,746
------------------------------------------------------------------------
                                                7,538,225     4,469,120
========================================================================
</TABLE>

See accompanying notes

                                        3
<PAGE>

                     DynaMotive Energy Systems Corporation
                   CONSOLIDATED STATEMENT OF LOSS AND DEFICIT
<TABLE>
<CAPTION>
                                            (expressed in U.S. dollars)
                                     Three       Three        Six       Six
                                    months      months      months    months
                                    ended       ended       ended      ended
                                   Sept 30,    Sept 30,    Sept 30,   Sept 30,
                                     2001        2000        2001       2000
                                       $           $          $           $
------------------------------------------------------------------------------
<S>                            <C>         <C>         <C>         <C>
REVENUE
Sales [note 8]                     362,292     138,760     805,227     584,511
------------------------------------------------------------------------------
                                   362,292     138,760     805,227     584,511
------------------------------------------------------------------------------

EXPENSES
Cost of sales                      190,719      94,340     507,036     371,346
Amortization and depreciation       81,055      73,841     241,347     218,937
Interest expense                    84,297      12,370      95,609      19,597
Marketing                          126,608     135,227     529,732     637,451
Office supplies, telephone
      and insurance                137,051      82,703     306,772     203,021
Professional fees [note 6]         242,742     616,953   1,527,206   1,417,270
Royalties                               --       3,613       1,805      21,865
Rent                                96,788      64,836     267,162     133,767
Research and Development
      [note 5b and 9]               88,581      66,623     308,402     237,648
General and administrative
  salaries and benefits [note 6]   540,664     249,020   1,339,739   1,140,964
------------------------------------------------------------------------------
                                 1,588,505   1,399,526   5,124,810   4,401,866
------------------------------------------------------------------------------
Loss from operations            (1,226,213) (1,260,766 )(4,319,583) (3,817,355)

OTHER REVENUE AND EXPENSES
Interest income                      8,020      13,886      18,445     125,841
Loss on asset disposals             (3,580)         --      (4,047)    (24,615)
Capital tax expenses                    --          --     (53,765)         --
------------------------------------------------------------------------------
                                     4,440      13,886     (39,367)    101,226
------------------------------------------------------------------------------
                                (1,221,773) (1,246,880) (4,358,950) (3,716,129)

Minority interest                   92,737          --     150,765          --
------------------------------------------------------------------------------
Loss for the Period             (1,129,036) (1,246,880) (4,208,185) (3,716,129)

Deficit, beginning of period   (22,013,933)(16,647,160)(18,934,784)(14,177,911)
------------------------------------------------------------------------------
Deficit, end of period         (23,142,969)(17,894,040)(23,142,969)(17,894,040)
==============================================================================

Weighted average number of
common shares Outstanding       36,257,840  34,048,212  35,258,963  32,138,953
------------------------------------------------------------------------------
Loss per common share              (0.03)      (0.04)       (0.12)      (0.12)
==============================================================================
</TABLE>
See accompanying notes
                                             4

<PAGE>

                     DynaMotive Energy Systems Corporation
                     CONSOLIDATED STATEMENT OF CASHFLOW

                                                  (expressed in U.S. dollars)
<TABLE>
<CAPTION>
                                                  Nine months   Nine months
                                                      ended         ended
                                                     Sept 30      Sept 30,
                                                      2001          2000
                                                        $             $
-----------------------------------------------------------------------------
<S>                                                <C>            <C>
OPERATING ACTIVITIES
Loss for the period                                (4,208,185)    (3,716,129)
Add items not involving cash:
     Amortization and depreciation                    241,347        218,937
     Minority interest                               (150,765)            --
     Loss on asset disposal                             4,047         24,615
     Stock based compensation                       1,635,822      1,616,220
Net change in non-cash working capital
balances related to operations [note 7]               236,505        (90,617)
------------------------------------------------------------------------------
Cash used in operating activities                  (2,241,229)    (1,946,974)
------------------------------------------------------------------------------

FINANCING ACTIVITIES
Increase in bank indebtedness                         132,167          91,966
Increase in loan from shareholder                      67,152              --
Increase in other loans                               208,327              --
Increase in convertible shareholders loan               6.553              --
Share capital issued                                1,805,673       4,436,129
------------------------------------------------------------------------------
Cash provided by financing activities               2.219,872       4,528,095
------------------------------------------------------------------------------

INVESTING ACTIVITIES
Increase in patents costs                             (23,105)        (29,280)
Increase in deferred project costs                   (113,180)             --
Purchase of capital assets (net of
  government grants)                                 (759,717)       (596,793)
------------------------------------------------------------------------------
Cash used in investing activities                    (896,002)       (626,073)
------------------------------------------------------------------------------

Effect of exchange rate changes on cash              (134,351)        (50,415)
------------------------------------------------------------------------------

Increase (decrease) in cash and cash
   equivalent during the period                    (1,051,710)       1,904,633
Cash and cash equivalent at beginning of period     1,095,715          223,769
------------------------------------------------------------------------------
Cash and cash equivalent at end of period              44,005        2,128,402
==============================================================================
</TABLE>

See accompanying notes
                                             5
<PAGE>

1. NATURE OF BUSINESS

DynaMotive Energy Systems Corporation ("the Company") was incorporated on
April 11, 1991 under the laws of the Province of British Columbia under the
name of DynaMotive Canada Corporation. The Company changed its name to
DynaMotive Technologies Corporation in 1995, and changed to its current
name in June 2001. Since its inception the Company has been engaged in the
process of commercializing several technologies that are in various stages
of development.

The Company's primary focus is to commercialize its patented BioOil
production technology and establish this technology as the worldwide
industry standard for production of BioOil clean fuels. With the recent
acquisition of Border Biofuels Ltd, the Company will gain access to BioOil
fuelled electricity projects in the United Kingdom over a 15-year period.
The Company has developed, patented, or acquired three primary technologies:
(1) BioTherm(tm), a biomass-to-energy technology that converts low value forest
waste and agricultural by-products into liquid BioOil, which can be used as
a fuel or as a raw material for the production of various derivative
products; (2) DynaPower(r), a metal cleaning process that does not involve
the use of chemicals; and (3) actuator technologies used in both steel and
aluminum welding. To date, the Company's principal revenues have been
derived from the sales of the actuators and sales of DynaPower(r) systems to
various customer applications. The principal market for the Company's metal
cleaning business is in the United States, while the principle market for
near term BioOil related business is in the UK.

These financial statements have been prepared on the going concern basis,
which presumes the Company will be able to realize its assets and discharge
its liabilities in the normal course of operations for the foreseeable
future.

The Company incurred a net loss of $4,208,185 for first nine months of 2001
and as at September 30, 2001 has a deficit of $23,142,969.

The ability of the Company to continue as a going concern is uncertain and
is dependent on achieving profitable operations, and continuing development
of new technologies, the outcome of which cannot be predicted at this time.
Accordingly, the Company will require, for the foreseeable future, ongoing
capital infusions in order to continue its operations, fund its research
and development activities, and ensure orderly realization of its assets at
their carrying value. The financial statements do not reflect adjustments
in carrying values and classifications of assets and liabilities that would
be necessary should the Company not be able to continue in the normal
course of operations.


2. SIGNIFICANT ACCOUNTING POLICIES

The consolidated financial statements have been prepared by management in
accordance with accounting principles generally accepted in Canada. A
reconciliation of amounts presented in accordance with United States
accounting principles is detailed in note 11.

The following is a summary of significant accounting policies used in the
preparation of these consolidated financial statements:


2. SIGNIFICANT ACCOUNTING POLICIES (cont'd.)

Principles of consolidation

These consolidated financial statements include the accounts of the Company
and its wholly-owned subsidiaries DynaMotive Corporation, incorporated
under the laws of Rhode Island, U.S.A.; DynaMotive Europe Limited (formerly
known as DynaMotive Technologies (UK) Limited), incorporated under the laws
of the United Kingdom; DynaMotive Canada Inc., federally incorporated under
the laws of Canada; DynaPower  Inc., incorporated under the laws of British
Columbia; DynaMotive Puerto Rico, Inc., incorporated under the laws of
Puerto Rico; DynaMill Systems Ltd. and  DynaMotive Electrochem Corporation,
incorporated under the laws of British Columbia. The consolidated financial
statements also include 75% of Border Biofuels Limited, incorporated under
the law of United Kingdom, acquired through DynaMotive Europe Limited.
DynaMotive Electrochem Corporation, and DynaMotive Puerto Rico, Inc. are
companies with no significant net assets or operations.

Use of estimates

The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the amounts reported in the financial statements
and accompanying notes. Actual results could differ from these estimates.

Foreign currency translation

The accounts of the Company and its consolidated subsidiaries are measured
using the Canadian dollar as the functional currency. Monetary items
denominated in foreign currencies are translated into Canadian dollars
using exchange rates in effect at the balance sheet date and non-monetary
items are translated using historical exchange rates. Exchange gains or
losses arising on the translation or settlement of foreign currency
denominated monetary items are included in the determination of net income,
except for gains or losses related to long-term monetary items which are
deferred and amortized over the life of the item.

The Company uses the U.S. dollar as the reporting currency for its
consolidated financial statements. Assets and liabilities are translated
into U.S. dollars using current exchange rates in effect at the balance
sheet date and revenue and expense accounts are translated using the
average exchange rate during the year. Gains and losses resulting from this
process are recorded in shareholders' equity as an adjustment to the
cumulative translation adjustment account.

Financial derivatives

Foreign currency derivative financial instruments, such as forward
contracts, are used from time to time to manage the effects of exchange
rate changes on foreign currency exposures. Gains and losses on forward
foreign exchange contracts are not recognized until realized and are then
charged to income on a basis that corresponds with changes in the related
amounts of foreign currency expenses.


2. SIGNIFICANT ACCOUNTING POLICIES (cont'd.)

Revenue recognition

Revenue from the sale of products is recognized upon shipment of the
product to the customer. Revenue from contracts relating to implementation
of the Company's metal cleaning systems in a commercial application is
recognized on a completed contract basis, except for those which are
greater than three months in duration, for which revenue is recognized on a
percentage of completion basis where the basis of measure of performance is
based on engineering estimates of completion. Revenue from power purchase
projects of acquired Border Biofuels operations (Note 12) is recognized on
a completed contract basis. Losses on contracts are recognized when they
become known.

Government assistance and investment tax credits

Government assistance towards current expenses is included in the
determination of income for the period as a reduction of the expenses to
which it relates. Government assistance towards the acquisition of capital
assets is deducted from the cost of the related capital assets.

Investment tax credits are accounted for under the cost reduction method
whereby they are netted against the expense or capital asset to which they
relate.

Investment tax credits are recorded when the Company has incurred the
qualifying expenditures and there is reasonable assurance the tax credits
will be realized.

Inventory

Inventory comprises of work in progress relating to the Company's products
under construction and is recorded at the lower of average cost and net
realizable value. Inventory work in progress costs include the cost of raw
materials, direct labour and overhead.

Research and development costs

Research costs are expensed in the year incurred. Development costs are
expensed in the year incurred unless the Company believes the development
project meets generally accepted accounting criteria for deferral and
amortization. In evaluating these criteria the Company considers
technological feasibility to be established only when a product
demonstrates it operates under conditions, which are acceptable to target
customers.

If management determines that the development of products to which such
costs have been capitalized is not reasonably certain, or that costs exceed
recoverable value, such costs are charged to operations.




2. SIGNIFICANT ACCOUNTING POLICIES (cont'd.)

Product warranties

A liability for estimated warranty expense is established by a charge
against cost of goods sold. The subsequent costs incurred for warranty
claims serve to reduce the product warranty liability.

Patents

Patents consist of the consideration paid for the patents and related legal
costs and are amortized over the lesser of the estimated useful life of the
related technology and the life of the patent commencing with commercial
production. If management determines that development of products to which
patent costs relate is not reasonably certain, or that costs exceed
recoverable value, such costs are charged to operations.

Due to the long-term nature of estimates inherent in determining future
cash flows, it is possible that the amounts or the estimated useful life of
such assets could be reduced in the future.

Capital assets

Capital assets are recorded at cost, net of government assistance, and
amortized using the following methods and annual rates:

Furniture and fixtures            20% declining balance
Computer equipment                30% declining balance
Computer software                 100% declining balance
Test equipment                    20% declining balance
Leasehold improvements            Straight line over the term of the lease

Cash equivalents

The Company considers all highly liquid financial instruments purchased
with an original maturity of three months or less to be cash equivalents
and are recorded at the amortized cost, which approximates fair value.

Financial instruments

The fair values of the financial instruments approximate their carrying
value except as otherwise disclosed in the financial statements.

Income taxes

The Company follows the liability method of tax allocation in accounting
for income taxes.




2. SIGNIFICANT ACCOUNTING POLICIES (cont'd.)

Stock based compensation plan

The Company has two stock based compensation plans - a stock appreciation
rights (SAR) plan and a stock option plan for directors, employees and
others, which are described in Note 4. Under the terms of the stock option
plan the Company may grant fixed options or options whose vesting is
contingent on future performance. No compensation is recognized when SAR's
and fixed or performance based stock options are granted to employees and
directors.

The Company has a compensation arrangement with an officer of the Company
whereby the officer receives a fixed number of common shares per month. The
Company records compensation expense monthly based on the month-end quoted
market price of the Company's stock.

In addition, the Company has entered into compensation arrangements, which
entitle non-employees to specific amounts, which can only be settled by
applying the amounts to exercise outstanding options to purchase common
shares monthly over a period of up to twelve months. The Company recognizes
compensation expense based on the fair value of the common stock issuable
under the arrangement, when related services are performed. The common
shares issuable under these arrangements are generally issued in the
quarter following the period in which they are earned.

The Company may also issue stock options, SAR's and warrants as
consideration for services rendered by non-employees. Such equity awards
are recorded at their fair value, as compensation expense when the Company
receives the related services and the equity awards vest. No compensation
is recognized in connection with options and warrants awarded in connection
with private placements, since the share issue costs are net against the
proceeds raised.

If shares or stock options are repurchased, the excess of the consideration
paid over the carrying value of the shares or stock options cancelled is
charged to contributed surplus or deficit.

Loss per common share

Loss per common share is based on the weighted average number of shares
outstanding for the year including escrowed shares. The effect of potential
issues of shares under share option, share purchase warrants and conversion
agreements have not been disclosed, as they are antidilutive.


3. BANK INDEBTEDNESS

[a] The Company has an authorized credit facility up to a maximum of
$316,957 [$Cdn. 500,000]. As collateral for the loan, the Company has
provided the lender a General Security Agreement providing a charge on all
present and future assets. Amounts borrowed are repayable within 120 days
from the date of borrowing and as at September 30, 2001, $285,261 (Cdn.
$450,000) has been drawn down on this loan.


3. BANK INDEBTEDNESS (cont'd.)

Covenants under the credit facility include, among other things, a
requirement for the Company to obtain written consent prior to declaring
dividends, significantly changing ownership control, committing to mergers,
acquisitions, or changes in Company's principal line of business or
entering other guarantees or other contingent liabilities and assets are
not to be further encumbered.

The fair market value of the loan on September 30, 2001 approximates its
carrying value.

[b] The Company's subsidiary Border Biofuels Limited (BBL) has extended a
credit facility agreement with Bank of Scotland for a maximum of $1,715,346
(1,162,789 pound sterling). Under this agreement, Bank of Scotland has the
security right over the assets of BBL and its subsidiaries. Interest charge is
calculated daily on annualized based rate plus 3%. The borrowed amount must be
repaid together with interest by Mach 30, 2004 or earlier from audited profits
generated in BBL and its subsidiaries prepared in accordance with UK GAAP.
As of September 30, 2001, $1,692,987 (1,147,632 pound sterling) has been drawn
down on the credit facility. The fair market value of the loan on September
30, 2001 approximates its carrying value.


Covenants to BBL under the credit facility include, among others, a
requirement for the Company to obtain written consent prior to declaring
dividends, significantly changing ownership control, committing to mergers,
acquisitions, or changes in Company's principal line of business, changing
the auditor, or providing other guarantees or entering contingent
liabilities and assets are not  to be further encumbered.


[c] The Company's subsidiary Border Biofuels Limited (BBL) has entered a
loan facility with Bank of Scotland for a maximum of $295,040 (200,000 pound
sterling).  Under this agreement, Bank of Scotland has the security right over
the assets of BBL and its subsidiaries. Interest charge is calculated daily on
annualized based rate plus 3%. The borrowed amount must be repaid together
with interest by March 30, 2003. The Company has provided a guarantee for
this amount. As of September 30, 2001, $322,815 (218,828 pound sterling) has
been drawn down on this facility. The fair market value of the loan on
September 30,2001 approximates its carrying value.

Covenants to BBL under the credit facility include, among others, a
requirement for the Company to obtain written consent prior to declaring
dividends, significantly changing ownership control, committing to mergers,
acquisitions, or changes in Company's principal line of business, changing
the auditor, or providing other guarantees or entering contingent
liabilities and assets are not  to be further encumbered.

[d] Included in Short-term Bank indebtedness is the Company's subsidiary
DynaMotive Europe Limited's bank overdraft of $20,722 (14,047 pound sterling)
as of September 30, 2001.

4. SHARE CAPITAL

[a]  AUTHORIZED SHARE CAPITAL AND ISSUED COMMON SHARES

<TABLE>
<CAPTION>
                                             September 30,    December 31,
                                                2001               2000
                                                  $                 $
------------------------------------------------------------------------------
<S>                                             <C>             <C>

Authorized
   100,000,000 common shares
   100,000,000 preferred shares Class A with $5.00 par value

Issued and outstanding

39,908,436 [December 31, 2000 - 35,851,060]      $24,084,098   $21,040,882
------------------------------------------------------------------------------
</TABLE>


[i]   Pursuant to a private placement on February 20, 2001, the Company issued
417,246 common shares for total cash proceed of $500,695.

[ii]  Pursuant to the closing of the May 2001 private placement, the Company
issued a total of 995,154 common shares for cash proceeds of $645,000 and
$151,125 in settlement of commercial fees.

[iii]  Pursuant to an interim closing of a private placement on August 20,
2001, the Company issued a total of 1,181,818 common shares for cash proceeds
of $600,000 and $50,000 in settlement of commercial fees.

[iv] 87,979 common shares were issued to directors in lieu of cash
compensation based upon reported share prices ranging from $0.81 to $0.94 per
common share.

[v] 1,225,233 common shares were issued as payment for commercial services
based upon reported share prices ranging from $0.50 to $2.00 per common share.

[vi]149,946 common shares were issued pursuant to the exercise of options at
$0.40 per common share for cash.

$0.40 per common share for cash.


<TABLE>
<CAPTION>
                                                     $         Number of Shares
-------------------------------------------------------------------------------
<S>                                                <C>             <C>

Share Capital, December 31, 2000                   21,040,882      35,851,060

Private placement issued for cash                   1,745,695       2,314,404
Private placement issued, non cash                    201,122         279,812
Shares issued from exercise of options for cash        59,978         149,946
Shares issued, directors & employees compensation      77,874          87,979
Shares issued, for commercial services                958,547       1,225,235
------------------------------------------------------------------------------
Balance, September 30, 2001                        24,084,098      39,908,436
------------------------------------------------------------------------------
At September 30, 2001, the Company has 182,100 Common shares to be issued to
an officer and non-employees for services rendered under compensation
arrangements
</TABLE>


4. SHARE CAPITAL (cont'd.)

Shares to be issued

At September 30, 2001, the Company has 105,895 common shares to be issued to
an officer and non-employees for services rendered under compensation
arrangements.

[b] Escrow agreement

At December 31, 1998, 1,232,000 common shares were held in escrow to be
released at a rate of one share for each $0.17 of "cash flow" as defined in
the agreement, generated by the Company.

During 1999, the Board approved an amendment to the Escrow agreement's release
provisions that applied to 676,000 of the shares held in escrow. The amended
release provisions are: 1/3 of the common shares in escrow will be released
upon the Company achieving a capitalized stock value of $30 million for a
consistent twenty day trading period; 1/3 of the common shares in escrow will
be released upon the Company achieving a capitalized stock value of $50
million for a consistent twenty day trading period; 1/3 of the common shares
in escrow will be released upon the Company achieving a capitalized stock
value of $100 million for a consistent twenty day trading period.

During the first nine months of 2001 no common shares were released from
escrow and at September 30, 2001,  781,334 common shares were held in escrow.

[c]  Stock Options

At September 30, 2001 the following stock options to Directors, employees and
others were outstanding:

<TABLE>
<CAPTION>
   No. of common      Exercise Price
  shares issuable            $           Date of expiry
------------------------------------------------------------------------------
<S>                        <C>           <C>
        549,236            0.40          October 28, 2001 - December 10, 2004
        100,000            0.50          January 31, 2005
        255,400            0.75          January 31, 2002 - January 31, 2004
        861,500            1.00          January 31, 2002 - February 28, 2005
      2,610,000            1.50          May 30, 2002 - May 31, 2006
         20,000            1.95          June 14, 2005
         34,222            2.00          July 31, 2001 - December 19, 2002
          6,000            2.75          December 1, 2002
         12,000            3.13          November 15, 2001
          3,985            4.00          October 31, 2002
         50,000            5.50          November 12, 2001
------------------------------------------------------------------------------
      4,502,343
==============================================================================
</TABLE>

From time to time, the Company has provided incentives in the form of share
purchase options to the Company's directors, officers and employees. The
Company has reserved 5,986,265 (15%) of common  shares for issuance upon the
exercise of stock options of which at September 30, 2001
1,483,922 are available to be granted. The exercise price and the vesting
terms of the options are determined by the Compensation Committee. The
exercise price will generally be at least equal to the market price  of  the
common shares at the date of the grant and the term may not exceed  five years
from the date of the grant. Stock options granted are also subject to certain
vesting provisions as determined by the Compensation Committee.

4. SHARE CAPITAL (cont'd.)

Stock option transactions for the respective periods and the number of stock
options outstanding are summarized as follows:


<TABLE>
<CAPTION>
                                       No. of Common       Weighted Average
                                      SHARES ISSUABLE       EXERCISE PRICE
------------------------------------------------------------------------------
<S>                                   <C>                       <C>
BALANCE, DECEMBER 31, 1997            1,547,385                 2.58
------------------------------------------------------------------------------
Options granted                         872,635                 0.46
Options cancelled                      (478,566)                2.48
Options exercised                       (96,943)                0.75
------------------------------------------------------------------------------
BALANCE, DECEMBER 31, 1998            1,844,511                 0.73
------------------------------------------------------------------------------
Options granted                       1,070,863                 1.11
Options cancelled                      (262,634)                0.97
Options exercised                      (242,601)                0.46
------------------------------------------------------------------------------
BALANCE, DECEMBER 31, 1999            2,410,139                 0.90
------------------------------------------------------------------------------
Options granted                       3,885,500                 1.17
Options cancelled                      (265,278)                1.63
Options expired                         (63,600)                2.26
Options exercised                      (737,119)                0.54
------------------------------------------------------------------------------
BALANCE, DECEMBER 31, 2000            5,229,642                 1.14
------------------------------------------------------------------------------
Options granted                         234,445                 1.22
Options cancelled                            --                   --
Options expired                         (15,000)                2.00
Options exercised                      (946,744)                0.74
------------------------------------------------------------------------------
BALANCE, SPETEMBER 30, 2001            4,502,343                1.55
------------------------------------------------------------------------------
</TABLE>


During 2000, the Company re-priced 234,278 options issued to non-employees
from original exercise prices ranging from $1.50 to $2.00 to a new exercise
price of $0.75, the then market price of the shares.

On December 14, 1998, the Company re-priced 318,000 options issued to
Directors from an original exercise price of $2.00 to $0.40. On December 10,
1999 these same options were re-priced again from $0.40 to $1.00.

Included in the options granted in 2001, were 60,000 options to a non-employee
for services rendered.  The valuation of this stock based compensation is to
be recorded at fair value when related services are performed.

4. SHARE CAPITAL (cont'd.)

[d]  Common share purchase warrants

(1) At September 30, 2001 common share purchase warrants outstanding were as
follows:


<TABLE>
<CAPTION>
                   Number of Common  Exercise  Expiration
                    Shares Issuable   Price      Date
------------------------------------------------------------------------------
<S>                  <C>              <C>      <C>
 Series F Warrants   2,075,000        $1.50    March 5, 2005
 Series G Warrants     300,000        $2.50    March 1, 2003
 Series H Warrants      15,000        $1.75    May 31, 2002
 Series I Warrants      15,000        $2.50    May 31, 2002
 Series J Warrants   1,005,000        $2.00    July 31, 2002-July 31, 2003
 Series K Warrants      75,000        $1.50    July 31, 2003
 Series L Warrants      83,448        $2.00    February 20, 2003
 Series M Warrants     589,041        $1.50    June 22, 2003-September 30, 2004
 Series N-a. Warrants  386,362        $1.50    March 5, 2002
 Series N-b. Warrants  386,365        $1.50    September 5, 2004
------------------------------------------------------------------------------
</TABLE>


(1) 2,000,000 of the Series F warrants were issued as an integral part of a
    subscription to a private placement. These warrants vested upon successful
    completion of the private placement.

    75,000 of the Series F warrants were issued to an employee of the Company
    for past services.

(2) The Series G warrants were issued as a placement fee for a private
    placement. These warrants vested upon successful completion of the private
    placement.
(3) The Series H, I, J, and K warrants have been issued for services. Of these
    warrants, 75,000 have been issued to an employee of the Company for past
    services. The remaining warrants have been issued to non-employees. The
    warrants remaining have the following vesting terms: 675,000 warrants vest
    monthly based on the consulting agreement term; 120,000 warrants vest upon
    completion of performance criteria; and, 315,000 warrants vested
    immediately upon grant.

(4) The Series L, M, N-a, N-b warrants have been issued as an integral part of
    private placements. These warrants vested upon successful completion of
    the private placements.

As at September 30, 2001, 120,000 warrants are unvested. Compensation for the
first nine months of 2001 in respect of the vested warrants has been recorded
at a fair value of $469,567.

4. SHARE CAPITAL (cont'd.)

[e]  Stock appreciation rights

During 1998, the Company established a stock appreciation rights plan whereby
the participants will be entitled to require the Company to redeem the stock
appreciation rights ("SAR's") for an amount equal to the excess of the market
value of the underlying common shares over the initial value of the SAR at the
date of grant.

The SAR's vest as the Company achieves stock values as defined in the
agreement: 1/3 of the SAR's issued may be redeemed upon the Company achieving
a capitalized stock value of $30 million for a consistent twenty day
trading period; 1/3 of the SAR's issued may be redeemed upon the Company
achieving a capitalized stock value of $50 million for a consistent twenty day
trading period; 1/3 of the SAR's issued may be redeemed upon the Company
achieving a capitalized stock value of $100 million for a consistent twenty
day trading period.


The Company also has the right to redeem the SAR's at its option under certain
circumstances. The number of SAR's that can be granted under the plan until
December 31, 2008 cannot exceed 2,500,000.

Stock appreciation rights transactions and the number of stock appreciation
rights outstanding at September 30, 2001 is summarized as follows:


<TABLE>
<CAPTION>
                                                           No. of
                                                        SAR's Issued
--------------------------------------------------------------------
<S>                                                         <C>
Balance, December 31, 1999 and 1998                       1,747,500
SAR's redeemed                                              (11,667)
--------------------------------------------------------------------
Balance, December 31, 2000                                1,735,833
--------------------------------------------------------------------
SAR's cancelled                                            (249,166)
--------------------------------------------------------------------
Balance, September 30, 2001                               1,486,667
--------------------------------------------------------------------
</TABLE>

At September 30, 2001, the following stock appreciation rights all of which
were issued to employees, were outstanding:


<TABLE>
<CAPTION>
           SAR's        Initial Value	                Expiration Date
---------------------------------------------------------------------
<S>                       <C>                            <C>
       1,132,502          $0.400	                   January 28, 2004
         200,000          $0.625	                        May 1, 2004
         154,165          $1.000	                        May 1, 2004
---------------------------------------------------------------------
       1,486,667
---------------------------------------------------------------------
</TABLE>

4. SHARE CAPITAL (cont'd.)

[f]  Contributed surplus

During 1994, the Company entered into an escrow agreement with certain
shareholders, Directors and employees, whereby the Company issued 2,512,720
common shares for cash consideration of $22,300.  During 1995, the Company
repurchased for cash 1,280,720 of these common shares at their original issue
price of $11,366. The excess of the weighted average cost of the 1,280,720
common shares repurchased and cancelled over the purchase price, amounting to
$409,030 ($Cdn. 560,315), has been credited to contributed surplus.

Contributed surplus also includes the fair value of stock options and warrants
issued to non-employees for services rendered.


5. COMMITMENTS AND CONTINGENCIES

Commitments

[a] Pursuant to an agreement to purchase certain patents, the Company is
committed to pay a royalty of $7,100 on each sale of a unit of related product
to a maximum of $106,500. No sales have occurred to September 30, 2001 on
which the Company owes such royalty.

[b] During the year ended December 31, 1997, the Company entered into a
contribution agreement with Industry Canada-Technology Partnerships Canada
whereby the Company is entitled to receive a maximum of approximately $6.1
million or 37% of eligible expenditures, as defined in the agreement. In the
event that commercial viability is achieved, then the assistance is repayable,
denominated in Canadian dollars, commencing February 15, 2002 based on
royalties from sales of specified products after December 31, 2001 resulting
from the project to a maximum of $11 million. During the first nine months of
2001, $547,735 was claimed and is included in government grants receivable
[see note 9]. The Company has yet to achieve commercial viability.

[c] The Company has available a maximum aggregate forward exchange contract
facility of up to $750,000 U.S. dollars or the equivalent thereof in other
approved currencies. The daily settlement limit is $250,000. No such
instruments were outstanding at September 30, 2001.

[d] The Company has the following future minimum lease commitments for
premises and equipment expiring through 2005:


<TABLE>
<CAPTION>
                                                              $
--------------------------------------------------------------------
<S>                                                         <C>
2001                                                         57,250
2002                                                        219,000
2003                                                        214,000
2004                                                        124,000
2005                                                        119,000
--------------------------------------------------------------------
                                                            733,250
--------------------------------------------------------------------
</TABLE>


5. COMMITMENTS AND CONTINGENCIES (cont'd)

Contingencies

In the ordinary course of business activities, the Company may be contingently
liable for litigation and claims with customers, suppliers and former
employees. Management believes that adequate provisions have been recorded in
the accounts where required. Although it is not possible to estimate the
extent of potential costs and losses, if any, management believes that the
ultimate resolution of such contingencies will not have a material adverse
effect on the consolidated financial position of the Company.

[a] In 1996 the Company was named as a co-defendant in a legal action for
unspecified damages for alleged interference with the rights to a
disintegration technology held by a subsidiary of the Company. The outcome of
the action is not determinable at this time and the amount of any liability,
if any, cannot be reasonably estimated. Accordingly, no provision for loss has
been made in these consolidated financial statements.

[b] The Company is a party to a legal proceeding filed by HPG Research Ltd.
for an alleged breach of a royalty agreement and a potential claim of a
certain percentage of DynaPower sales. The parties have agreed to proceed with
arbitration, as provided for under the agreement.

[c] At the end of the first quarter 2001, the Company was named a party to a
legal proceeding filed by Southwestern Wire, Inc. (SWI), an Oklahoma
corporation, in the District Court of Cleveland County, State of Oklahoma for
an alleged breach of contract by the Company with respect to SWI's purchase of
a 24 wire DynaPower(r) cleaning system for a potential claim of $101,000. The
outcome of the action is not determinable at this time and the amount of any
liability, if any, cannot be reasonably estimated. Accordingly, no provision
for loss has been made in these consolidated financial statements.


6. RELATED PARTY TRANSACTIONS

In addition to the transactions described in Note 4, the Company had the
following transactions with related parties:

[a] Consulting fees and salaries of $415,979 for first nine months of 2001
and $365,430 for the first nine months of 2000 have been paid to Directors (or
companies controlled by Directors) of the Company.

[b] The Company's subsidiary Border Biofuels Limited has loan agreement with
two of its directors totaling $326,926 (231,012 pound sterling). The loan bear
interest at annual LIBOR rate plus 3.5% calculated monthly. The loan, which
has the similar repayment term as that of Bank of Scotland loan (Note 3[b]),
is repayable upon Border Biofuels Ltd. achieving net positive relevant profit
under Generally Accepted Accounting Principles in the United Kingdom
("UK GAAP").  Relevant profit is defined as the amount obtained by deducting
the accumulated liabilities from the retained profit, at any given time.


6. RELATED PARTY TRANSACTIONS (cont'd)

The Company's subsidiary Border Biofuels Limited also has loan agreements
with its shareholders totaling, $158,796 (112,208 pound sterling). These loans
can be conditionally converted to DynaMotive's common shares at the higher
rate of $3.00 per share or the prevailing market price at the time BBL
achieves net positive relevant profit under UK GAAP.  Relevant profit is
defined as the amount obtained by deducting the accumulated liabilities from
the retained profit, at any given time. As of September 30, 2001, the
outstanding loan amount, approximating its carrying value, is $161,082
(109,193 pound sterling).

[c] The Company has entered into:

[i] A royalty agreement, pursuant to an agreement to purchase certain patents
for an unlimited term with a company controlled by a previous Director of the
Company, based on 4% of the gross receipts from unit sales. No sales have
occurred to date.

[ii] A royalty agreement during 1993, pursuant to the use of certain
proprietary information, with a company controlled by a former officer of the
Company to pay the greater of $7,100 in 1996 and increasing by $3,600 each
subsequent anniversary or 10% of the net proceeds of the sale of the
components, for each anniversary date, developed from certain proprietary
information for an unlimited term. If the Company fails to make a payment as
required, it will forfeit all rights relating to the agreement including any
patents or sub-licenses to third parties. No royalty expense has been recorded
for 2001.

[iii] During 2000, the Company entered into a 24-month consulting and
research agreement, expiring February 9, 2002, with a company controlled by a
board member of the Company. The contract fees are $10,000 ($15,000 Cdn) per
month. The agreement is extendable annually by mutual agreement. Included in
research and development expenses are fees of $90,000 to this related party.

7. NET CHANGE IN NON-CASH WORKING CAPITAL BALANCES

<TABLE>
<CAPTION>
                                            Nine months          Nine months
                                              ended               ended
                                           Sept 30, 2001       Sept 30, 2000
                                                $                   $
-----------------------------------------------------------------------------
<S>                                         <C>                 <C>
Accounts and government
  grants receivable                          136,259              54,877
Work in progress/Inventory                     3,409              35,156
Prepaid expenses and deposits               (172,512)           (213,395)
Accounts payable and accrued liabilities     320,868               4,469
Deferred revenue                             (51,519)             28,276
-----------------------------------------------------------------------------
                                             236,505             (90,617)
=============================================================================
Supplementary information
-----------------------------------------------------------------------------
Interest paid                                 95,609              19,597
=============================================================================
</TABLE>

8. MAJOR CUSTOMERS

[a] The Company sells to multiple customers. The majority of sales for the
nine months ended September 30, 2001 were derived from 3 customers each
representing 44%, 13%, and 13%, respectively of consolidated sales. The
majority of sales for the year ended September 30, 2000 were also derived from
3 customers each representing 52%, 36 and 12% respectively of consolidated
sales.  As at September 30, 2001 the aggregate accounts receivable balances
relating to these customers was $192,931 (September 30, 2000 - $40,741).

[b] During the year ended December 31, 1997 the Company entered into an
exclusive royalty licensing agreement with a major customer which provides
that customer the rights to the use of certain technology developed by the
Company for the production of actuators for welding applications. The
licensing agreement provides for a five year non-competition period
specifically related to stud welding.  No licensing revenue have been
recognized for the period ended September 30, 2001.


9. GOVERNMENT ASSISTANCE

Government assistance in the amount of $1,004,922 has been recorded as a
reduction of expenditures for the first nine months of 2001.

In addition to government assistance disclosed in note 5[b], during 2000, the
Company entered into a contribution agreement with Natural Resources Canada
whereby the Company is entitled to receive a maximum of $163,623 (Cdn -
$250,000) as defined in the agreement. The contribution is non-repayable. In
2000, $163,623 was claimed of which 100% has been received by September 30,
2001.

During the first quarter of 2001, the Company's subsidiary Border Biofuels
Limited (BBL) entered into a contribution agreement with Department of Trade
and Industry (DTI), a department of the United Kingdom government, whereby BBL
and its collaboration partners are entitled to receive $1,696,694 (1,161,300
pound sterling) under the New & Renewable Energy Programme between January 9,
2001 and July 8, 2003.  DynaMotive is named one of the collaboration partners
to the program. Except for the proceeds from disposing project assets, the
contribution is non repayable. As at September 30, 2001, $411,459 has been
claimed of which $96,918 is included in  government grants receivable as at
September 30, 2001.



10. SEGMENTED INFORMATION

The Company has nine reportable segments. The segments are DynaPower(r),
Actuators, BioThermTM, Corporate, Border Biofuels, and Other. DynaPower(r) is a
process for cleaning metal without the use of chemicals. The actuator
technology is used in both steel and aluminum welding. BioThermTM is a
biomass-to-energy technology that converts low value forest waste and
agricultural by-products into BioOil, while Corporate consists of interest and
administrative costs. Acquired subsidiary operation Border Biofuels
specializes in the development of green power projects in the United Kingdom.
Other includes a pulverizing technology, which disintegrates a variety of
solid materials and organic waste into a form suitable for the production of
BioOil.

The accounting policies of the segments are the same as those described in the
summary of significant accounting policies. The Company evaluates performance
based on many factors, including net income or loss.

The Company's reportable business segments are strategic business units that
offer different products and services. They are managed separately because
each business requires different technology and marketing strategies.


<TABLE>
<CAPTION>
                                            September             September
                                              2001                  2000
                                                $                     $
------------------------------------------------------------------------------
<S>                                       <C>                   <C>
REVENUE
Actuator                                        --                     --
DynaPower(R)                                 276,552              583,700
BioTherm(TM)                                      --                  811
Other                                             --                   --
Border Biofuels                              528,675                   --
Corporate                                         --                   --
------------------------------------------------------------------------------
                                             805,227               584,511
------------------------------------------------------------------------------
LOSS FOR THE PERIOD
Actuator                                     (15,403)              (13,118)
DynaPower(R)                                (261,854)             (244,628)
BioTherm(TM)                                (699,821)             (803,731)
Other                                        (30,019)              (11,990)
Border Biofuels                             (602,450)                   --
Corporate                                 (2,598,638)           (2,642,662)
------------------------------------------------------------------------------
                                          (4,208,185)           (3,716,129)
------------------------------------------------------------------------------
</TABLE>


10. SEGMENTED INFORMATION (cont'd)


<TABLE>
<CAPTION>
                                           September            December
                                              2001                2000
                                                $                   $
----------------------------------------------------------------------------
<S>                                          <C>                   <C>
CAPITAL EXPENDITURES, INCLUDING PATENTS
(NET OF GRANT & DISPOSAL)
Actuator                                         --                    --
DynaPower(R)                                  11,802               111,557
BioTherm(TM)                                 276,254             1,110,863
Other                                         42,856                 3,984
Border Biofuels                              440,203                    --
Corporate                                     11,707               224,463
------------------------------------------------------------------------------
                                             782,822             1,450,867
------------------------------------------------------------------------------
</TABLE>


<TABLE>
<CAPTION>
                                           September              September
                                              2001                  2000
                                                $                     $
------------------------------------------------------------------------------
<S>                                          <C>                   <C>
AMORTIZATION
Actuator                                      15,403                13,118
DynaPower(R)                                  74,445                72,064
BioTherm(TM)                                  84,493                96,448
Other                                          8,959                11,990
Border Biofuels                               17,368                    --
Corporate                                     40,679                25,317
------------------------------------------------------------------------------
                                             241,347               218,937
------------------------------------------------------------------------------
</TABLE>


<TABLE>
<CAPTION>
                                            September             December
                                              2001                  2000
                                                $                     $
------------------------------------------------------------------------------
<S>                                        <C>                  <C>
TOTAL ASSETS
Actuator                                      40,748               63,737
DynaPower(R)                                 376,873	              476,462
BioTherm(TM)                               1,606,567            1,429,496
Other                                        130,482               75,295
Border Biofuels                            2,535,280                   --
Corporate                                  2,848,275            2,424,130
------------------------------------------------------------------------------
                                           7,538,225            4,469,120
------------------------------------------------------------------------------
</TABLE>

10. SEGMENTED INFORMATION (cont'd)

Geographic Information

The Company holds substantially all of its capital assets in Canada and UK,
and revenues from external customers by customer location is as follows:

<TABLE>
<CAPTION>
                                           September              September
                                              2001                  2000
                                                $                     $
------------------------------------------------------------------------------
<S>                                           <C>                  <C>
Revenue
United States                                112,019               505,860
Italy                                          5,478                11,206
Canada                                       109,908                62,491
France                                        48,787                    --
United Kingdom                               529,035                    --
Other                                             --                 4,954
------------------------------------------------------------------------------
                                             805,227               584,511
------------------------------------------------------------------------------
</TABLE>


11. RECONCILIATION OF GENERALLY ACCEPTED ACCOUNTING  PRINCIPLES

The Company prepares the consolidated financial statements in accordance with
accounting principles generally accepted in Canada ("Canadian GAAP"), which
conform in all material respects to those in the United States ("U.S. GAAP"),
except as follows:

[i] Under U.S. GAAP, basic earnings per share excludes any dilutive effects
of options, warrants, convertible securities and shares in escrow. Diluted
earnings per share are calculated in accordance with the treasury stock method
and are based on the weighted average number of common shares and dilutive
common share equivalents outstanding.

[ii] Under U.S. GAAP, the excess, if any, between the fair value of the
shares in escrow and the nominal amount paid, will be recorded as compensation
expense upon release from escrow.

[iii] Under U.S. GAAP, patent costs are amortized over the life of the patent
commencing with the date the patent is granted.

[iv] Under U.S. GAAP, stock based compensation to non-employees is recorded
at the fair market value of the shares issued.


RECONCILIATION OF GENERALLY ACCEPTED ACCOUNTING PRINCIPLES (cont'd.)

[v] For reconciliation purposes to U.S. GAAP, the Company has elected to
follow Accounting Principles Board Opinion No. 25 "Accounting for Stock Issued
to Employees" (APB 25) in accounting for its employee stock options. The
exercise price of 70,000 (1999 - 33,196; 1998 - 316,969) fixed employee stock
options granted in 2000 was less than the market price of the underlying stock
on the date of the grant.   The exercise price of fixed employee stock options
granted in 2001 were greater than the market price of the underlying stock on
the date of the grant.

[vi] For purposes of reconciliation to U.S. GAAP, the re-pricing of options
can give rise to additional compensation expense. During the first nine months
of 2001 no compensation expense resulted from the re-pricing of options based
on the transition provision of FIN44, commencing July 1, 2000. Options re-
priced after December 15, 1998 are subject to variable plan accounting under
U.S. GAAP. In the pro forma information on net income and earnings per share,
pursuant to the provisions of Statement of Financial Accounting Standards No.
123 "Accounting for stock based compensation" ("SFAS 123"), additional
compensation expense in respect of the re-pricing of the options has been
reflected.

[vii] For purposes of reconciliation to U.S. GAAP, the stock
appreciation rights ("SAR's") and performance based stock options are
accounted for as a variable compensation plan under APB 25. Compensation
relating to variable plans is recorded in the reconciliation when it becomes
probable that the award will be earned.

[viii] For purposes of reconciliation to U.S. GAAP, the Company presents the
disclosure requirements of Financial Accounting Standard No. 130 ("SFAS 130")
in these consolidated financial statements. SFAS 130 requires the presentation
of comprehensive income and its components. Comprehensive income includes all
changes in equity during a period except shareholder transactions. Other
accumulated comprehensive income comprises only the cumulative translation
adjustment.


If accounting principles generally accepted in the United States were
followed, the significant variations on the consolidated statements of loss
and comprehensive loss would be as summarized in the table below.

11. RECONCILIATION OF GENERALLY ACCEPTED ACCOUNTING PRINCIPLES (cont'd.)


<TABLE>
<CAPTION>
                                       Three     Three      Nine      Nine
                                       months    months    months    months
                                       ended     ended      ended     ended
                                      Sept 30,  Sept 30,   Sept 30,  Sept 30,
                                        2001      2000      2001       2000
                                          $         $         $          $
------------------------------------------------------------------------------
<S>                                <C>        <C>        <C>        <C>
Loss for the period, Canadian GAAP (1,129,036)(1,246,880)(4,208,185)(3,716,129)
Adjustment for patent
    cost amortization                     249     (1,127)    (3,664)     8,940
Adjustment for stock-based compensation(4,167)   (12,075)   (15,136)   (12,075)
------------------------------------------------------------------------------
Loss for the year, as adjusted     (1,132,954)(1,260,082)(4,226,985)(3,719,264)
------------------------------------------------------------------------------
Unrealized losses on foreign
    currency translation             (156,375)    25,650   (182,365)   (51,303)
-------------------------------------------------------------------------------
Loss for the year, as adjusted     (1,289,329)(1,234,432)(4,409,350)(3,770,567)
-------------------------------------------------------------------------------
Weighted average number of
      common shares outstanding    36,257,840  34,048,212 35,258,963 32,138,953
-------------------------------------------------------------------------------

Loss per common share                 (0.04)     (0.04)     (0.13)      (0.12)
==============================================================================
</TABLE>

The three months ended March 31, 2000, six months ended June 30, 2000 and nine
months ended September 30, 2000  balances have been restated.  A schedule of
the restatements is detailed in note 13.

Consolidated balance sheet items which vary significantly under accounting
principles generally accepted in the United States would be as follows:


<TABLE>
<CAPTION>
                                         September 30,            December 31,
                                             2001                   2000
                                              $                      $
------------------------------------------------------------------------------
<S>                                    <C>                     <C>
Patents                                    627,396                 651,558
==============================================================================
Total assets                             7,505,605               4,390,740
==============================================================================

Share capital                           26,517,182              23,409,409
Share to be issued                          82,831                 250,713
Contributed surplus                      2,151,160               1,584,997
Cumulative translation adjustment         (553,427)               (371,062)
Deficit                                (25,608,676)            (21,381,691)
------------------------------------------------------------------------------
Shareholders' equity                     2,589,070               3,492,366
==============================================================================
</TABLE>

11. RECONCILIATION OF GENERALLY ACCEPTED ACCOUNTING PRINCIPLES (cont'd.)

The weighted-average fair value of options granted in 2001 where the stock
price is equal to the exercise price of the options, greater than the exercise
price of the options and less than the exercise of the options was $0.00,
$0.00, and $0.67 respectively.

The Black Scholes options valuation model was developed for use in estimating
the fair value of traded options, which have no vesting restrictions and are
fully transferable. In addition, option valuation models require the input of
highly subjective assumptions including the expected stock price volatility.
Because the Company's employee stock options have characteristics
significantly different from those of traded options, and because changes in
the subjective input assumptions can materially affect the fair value
estimate, in management's opinion, the existing models do not necessarily
provide a reliable single measure of the fair value of its employee stock
options.

Pro forma information regarding net income and earnings per share as required
by Statement of Financial Accounting Standard No. 123 "Accounting for stock
based compensation" ("SFAS 123"), is estimated at the date of grant using a
Black Scholes pricing model with the following assumptions: Risk free interest
rate for 2001 of 5.0%, dividend yields of 0%; volatility factors of the
expected market price of the Company's common stock of 1.303 and a weighted
average expected life of the option of 5 years.

Supplemental disclosure of pro forma loss and loss per share:

<TABLE>
<CAPTION>
                                           September 30 2001     June 30, 2000
------------------------------------------------------------------------------
<S>                                               <C>               <C>
Pro forma loss                                  4,226,985         3,716,264
Pro forma loss per share                            (0.12)            (0.12)
==============================================================================
</TABLE>


12. ACQUISTION OF BORDER BIOFUELS LIMITED

The Company acquired 75% of the outstanding common shares of Border Biofuels
Limited's (BBL), a United Kingdom Green Power project development company, on
April 6, 2001 for a nominal cash consideration of 1 pound sterling. The
Company has the option to acquire the balance of BBL's equity (25%) for
$1,570,704 (1,108,628 pound sterling) in DynaMotive stock at the higher rate
of $3.00 per share or the prevailing market price at the time BBL achieve net
positive relevant profit under UK GAAP. Relevant profit is defined as the
amount obtained by deducting the accumulated liabilities from the retained
profit, at any given time.

Furthermore, as part of the transaction, BBL restructured its debt with its
Bankers ($1,645,567 (1,162,789 pound sterling), see Note 3[b]). This debt will
be repaid from profits generated by BBL with no recourse to the Company.
Further in connection with the acquisition, the Company provided a guarantee
of $283,038 (200,000 pound sterling) to BBL's banker.


12. ACQUISTION OF BORDER BIOFUELS LIMITED (cont'd.)

The acquisition of BBL was accounted using the purchase method. The
consolidated financial statement reflected the results of operation of Border
Biofuels Limited from the date of acquisition through September 30, 2001. The
total  assets acquired amounted to $4,000,115 (2,825,730 pound sterling), and
the total liabilities acquired were $3,402,482 (2,404,258 pound sterling). The
net asset was calculated to be $597,633 (421,472 pound sterling), of which
$149,427 (105,368 pound sterling) represented minority interest. Given the
purchase price of 1 pound sterling, the acquisition resulted in a negative
goodwill (75%) of $448,225 (316,102 pound sterling). This amount is used to
reduce the corresponding portion of acquired BBL goodwill from prior
investments ($365,249, (257,798 pound sterling)). The remaining credit balance
was used to reduce deferred project costs ($82,606, (58,305 pound sterling)).


13.  Changes in Prior Year Balances

Certain options, warrants and shares issued to non-employees were issued at a
price other than market price in the prior year.  The prior year's nine month
ended  September 30, 2001 balances have been restated as follows:

<TABLE>
<CAPTION>
                                  Three       Three       Three       Nine
                                  months      months      months      months
                                  ended       ended        ended      ended
                                  Mar 31,     Jun 30,     Sept 30,    Sept 30,
                                   2000        2000         2000        2000
                                     $          $            $           $
-------------------------------------------------------------------------------
<S>                              <C>         <C>         <C>         <C>
Deficit as at December 31,1999   14,177,911  15,326,966  16,229,676  14,177,911
Net loss for the period before
   Restatements                   1,149,055     902,710     753,903   2,805,668
-------------------------------------------------------------------------------
Deficit before restatements      15,326,966  16,229,676  16,983,579  16,983,579
-------------------------------------------------------------------------------
Restatements for the period
  Balance b/f previous quarter           --     290,568     417,483          --
  Marketing expenses                  6,875      30,491          --      37,366
  Office supplies, Telephone
      And insurance                 (15,617)     75,418     (26,569)     33,232
  Professional fees                 283,693      96,424     843,234   1,223,351
  General & administrative salaries      --          --         (15)       (15)
  Board compensation & staff bonus       --          --    (276,665)  (276,665)
  Overtime settlement expenses           --          --     (65,616)   (65,616)
  SAR Redemption                         --          --      (7,960)    (7,960)
  Interest & other income            15,617     (75,418)     26,569    (33,232)
-------------------------------------------------------------------------------
Total adjustments c/f to
      next period                   290,568     417,483     910,461     910,461
-------------------------------------------------------------------------------

Deficit after restatements       15,617,534  16,647,159  17,894,040  17,894,040
===============================================================================

Weighted average number of
     Common shares outstanding   29,626,768  33,915,151  34,048,212  32,138,953
-------------------------------------------------------------------------------
Loss per common share after
      restatements                   (0.05)     (0.04)      (0.04)       (0.12)
-------------------------------------------------------------------------------
</TABLE>


14. Subsequent Events
In October, continued from an on-going private Common Share offering, the
Company received  further subscription commitments for total cash proceeds of
$227,649.


15. Comparative Figures

Certain comparative figures have been reclassified in order to conform with
the presentation adopted in the current year.


ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF
         FINANCIAL CONDITION AND RESULTS OF OPERATIONS
This Quarterly Report on Form 10-Q may contain forward looking statements,
within the meaning of the United States Securities Act of 1933, as amended,
and the United States Securities Exchange Act of 1934, as amended, regarding
DynaMotive Energy Systems Corporation. Actual events or results may differ
materially from the Company's expectations, which are subject to a number of
known and unknown risks and uncertainties including but not limited to changes
and/or delays in product development plans and schedules, customer acceptance
of new products, changes in pricing or other actions by competitors, the
ability to integrate the acquisition of Border Biofuels Limited. with the
business of the Company, and general economic and market conditions. Other
risk factors discussed in the Company's past filings with the United States
Securities and Exchange Commission may also affect the actual results achieved
by the Company.

The following discussion and analysis should be read in conjunction with the
financial statements and notes thereto included elsewhere herein. The
Company's quarterly operating results have been and will continue to be
affected by a wide variety of factors that could materially and adversely
affect revenues and profitability. These include factors relating to
competition, such as competitive pricing pressure and the potential
introduction of new products by competitors; manufacturing factors, including
constraints in the Company's supply of products from outside manufacturing and
assembly operations and shortages or increases in the prices of raw materials
and components; sales and distribution factors, such as changes in customer
base or distribution channels resulting in lower margins or the loss of a
significant alliance partner; new product development and introduction
problems, such as increased research, development, marketing and beta test
expenses associated with new product introductions, and delays in the
introduction of new products and technologies; as well as other factors,
including levels of expenses relative to revenue levels, personnel changes,
expenses that may be incurred in litigation, and fluctuations in foreign
currency exchange rates. The Company has experienced and expects to continue
to experience fluctuations in operating results, and there can be no assurance
that the Company will achieve profitability in the future.

In this Report, unless the context otherwise requires, the terms the "Company"
and "DynaMotive" refer to DynaMotive Energy Systems Corporation and its
subsidiaries. The Company is currently listed on the over-the-counter bulletin
board (OTCBB) under the symbol: DYMTF.OB.

1. Introduction

DynaMotive Energy Systems Corporation is a world leader in the development of
technology to produce competitively priced fuels from renewable and non-
depleting biomass. DynaMotive's liquid fuel, known as BioOil, presents
significant market opportunities that the Company intends to exploit
commercially as a clean fuel to replace natural gas, diesel and other fossil
fuels to produce power and heat in industrial boilers, gas turbines and diesel
engines. The Company and its partners are also engaged in research and
development on a range of derivative products that, if successful, could
further enhance the market and value for BioOil as an alternative fuel and
product source.

DynaMotive's primary focus is to commercialize its patented BioOil production
technology and establish this technology as the worldwide industry standard
for production of BioOil clean fuels. To support this goal the Company plans
over the next two years to expand upon its existing operations in Canada,
Europe and the US, as well as to develop commercial presence in Asia and Latin
America.

During the second quarter of 2001, the Company acquired 75% of the outstanding
common shares of Border Biofuels Limited, a UK Green Power project
development company, for a cash consideration of 1 pound sterling, along with
a guarantee of 200,000 pound sterling of Border Biofuels's indebtedness. The
transaction also provided the Company a right to purchase the balance of
Border BioFuels for 1,108,628 pound sterling in DynaMotive stock at the higher
rate of $3.00 per share or the prevailing market price at the time BBL
achieves profitability. Border Biofuels owns 69 Megawatts of BioOil fuelled
electricity projects under 15-year power purchase agreements under the Non
Fossil Fuel Obligation and Scottish Renewable Obligation programs of the UK
government. Revenues under these agreements could potentially exceed
$800,000,000 over the 15-year period.

As of  September 30, 2001, DynaMotive and its wholly owned subsidiaries have
active inventions protected by patents issued and patents pending via in-house
development or license, with the earliest U.S. patent scheduled to expire on
December 3, 2010.

2. Results Of Operations

The Company's financial statements have been prepared in accordance with
accounting principles generally accepted in Canada.  A reconciliation of
amounts presented in accordance with United States accounting principles is
detailed in note 11 of the Company's consolidated financial statements.
Financial information concerning the Company's industry segments is summarized
in Note 10 to Consolidated Financial Statements.

Total sales revenues for the third quarter of 2001 increased to $362,292 while
the same quarter for 2000 generated $138,760 of revenues.  Revenue for the
third quarter of 2001 was higher than the same quarter in 2000 due to
inclusion of revenue from newly acquired subsidiary Border Biofuels.
On a comparative basis, revenue generated from the Company's metal cleaning
business for the first nine months of 2001 and 2000 were $276,552 and
$583,700, respectively. This decrease was due to a decline in commercial sales
volume of its DynaPower(r) metal cleaning systems.

On May 1, 2001, the Company announced that it intends to divest its metal
cleaning subsidiary, DynaPower Inc., and has entered into a Letter of Intent
for a potential management buy-out. The Company intends to retain ownership of
certain patents connected with its metal cleaning technology and to continue
to receive royalty payments from these patents. While the Company intends to
complete the divestiture by the fourth quarter of this year, there can be no
assurance that the divestiture will be completed by the end of the fourth
quarter of 2001 or at all.

Cost of sales in the third quarter of 2001 increased to $190,719, from $94,340
in the same period of 2000 due to corresponding increases in sales.  For the
three months ended September 30, 2001, the gross margin was 47.4% compared to
32.0% in the same period of 2000.  The quarter-to-quarter increase in gross
margin is due to higher profitability generated from the newly acquired Border
Biofuels operations.

For the third quarter of 2001 and 2000 the Company expended $166,419 and
$130,414 respectively on research and development. Of these amounts, $77,838
and $63,791 respectively were sponsored by government funding.  For the first
nine months of 2001 and 2000, the Company expended $506,994 and $488,120,
respectively on research and development. Of these amounts, $198,592 and
$250,472 respectively were sponsored by government funding.  The increase in
research and development expenditures in 2001 reflects the increased
activities in the Company's commercialization effort.

General and administrative salaries and benefits increased to $540,664 in the
third quarter of 2001 compared to $249,020 in the same period of 2000.  The
increase reflects the increased cost structure resulting from the acquisition
of Border Biofuels.

Overall capital expenditures, net of government grants and disposals, for
developing and patenting the Company's technologies totaled $782,822 in the
first nine months of 2001. For the same period in 2000, total capital
expenditures were $626,073.  The increase is due primarily to the acquisition
of Border Biofuels.

The Company's total assets increased to $7,538,225 at September 30, 2001 from
$4,469,120 at December 31, 2000.  The increase is due primarily to the
acquisition of Border Biofuels. Liabilities increased to $4,755,453
at the end of the third quarter from $898,374 at December 31, 2000 also due
to the acquisition of Border Biofuels.

The operating loss for the nine month period ending September 30 2001 was
$4,208,185 as compared to $3,716,129 for the same period in 2000.  The
increase in loss is primarily due to (i) an increase in overhead expenses such
as occupancy, office expenses, and administrative salaries, resulting from the
acquisition of Border Biofuels, and (ii) an increase in professional
fees paid to independent consultants assisting in the Company's
commercialization effort. The majority of such fees were paid in restricted
common stock or warrants to purchase common stock.

Use of cash in operating activities for the nine month period ending September
30, 2001 increased to $2,354,409 from $1,946,974 in the same period in 2000.
The increase in use of cash was primarily due to the increase in operating
losses for the nine month period, which was substantially offset by non-cash
equity compensation, and changes in working capital consisting of accounts
receivables, government grant receivables, deferred revenue, and accounts
payables.

The end-of-period deficit increased from $18,934,784 at December 31, 2000 to
$23,142,969 at September 30, 2001.  The loss per common share for the third
quarter of 2001 decreased to three cents ($0.03) as compared to four cents
($0.04) for the same quarter in 2000.

During the third quarter, DynaMotive and its alliance partner, Tecna SA,
jointly announced that they are fast tracking the design and construction of
pyrolysis (BioOil) plants.  The Company's objective is to develop a modular
design that will allow for a "building block approach" to expanding plant
capacity. Plant modules will be fabricated in shops and shipped to locations
for final assembly.  Plant construction is being considered for Canada, the
United States and United Kingdom.

DynaMotive also announced during the third quarter that it has formally
launched the design of a 100 tonne per day (tpd) pyrolysis plant that will be
the core of an integrated biomass-to-energy system. The plant capacity
represents a 400% increase in capacity from its original plan. The 100 tpd
plant is projected to produce enough fuel to continuously fire a 2.5 Megawatt
turbine and be capable of providing electricity to a small town (2,000
households).

DynaMotive expects to demonstrate the commercial feasibility of its BioOil
fueled system in cooperation with Orenda Turbines, part of Magellan Aerospace
of Canada, and Border Biofuels. The flagship project is expected to generate
2.5 Megawatt and be the first BioOil power generation plant of its kind.
DynaMotive is currently evaluating sites for the commercial scale energy
system.

DynaMotive and Border BioFuels have submitted planning applications to develop
a Forest Residue fired power station on Arran, an Island off the Scottish
coast. The project intends to use wood from sustainable production in existing
forestry operations on the island to generate 'green' electricity. The power
station should generate up to one third of the island's electricity needs. The
scheme has the benefit of an electricity supply contract awarded under the
Scottish Renewables Obligation, a government project designed to foster the
development of energy from renewable sources in recognition of its
environmental advantages. The venture also has the support of the Forestry
Commission which will provide the wood fuel for the plant. Project revenues
have been estimated  to exceed $ 30 million over the project primary period of
15 years.


3. Liquidity And Capital Resources

The Company's BioOil technologies are consistent with the environmental and
economic objectives of governments around the world. The Company has received
strong support from the Canadian federal government and is in discussion with
other governments and international agencies in target markets directly and
through project partners to examine BioOil financing and grant potential.
Canadian government support has been received from Industry Canada/ Technology
Partnerships Canada (TPC), which has agreed to contribute Cdn. $8.2 million
(US $6.1 million) to DynaMotive for the development and commercialization of
BioOil fuels and derivative products, and Natural Resources Canada
which has contributed $250,000 to support research and development of BioOil
both in house and at CANMET national laboratory. In addition, DynaMotive
Europe Limited together with Border Biofuels and a strategic partner, received
a grant commitment of $1.7 million from the United Kingdom Department of Trade
and Industry to support the development of an integrated BioOil and
electricity generating plant in the UK. During the third quarter of 2001, the
Company continued working with TPC to revise the contribution agreement
entered into in 1997.

As of the end of the third quarter of 2001, the Company had cash and cash
equivalents of $44,005, representing a decrease of $1,051,710 from cash and
cash equivalents as at December 31, 2000. The primary sources of liquidity for
the Company during the third quarter of 2001 was the Company's private
placement offerings and stock option exercises for cash totaling $1,138,373.

During the first nine months of 2001, the Company generated cash in the amount
of $2,219,872 from financing activities, and used cash in operating and in
investing activities in the amounts of $2,354,409, and $782,822, respectively.
For the same period in 2000, the Company used cash in operating and in
investing activities in the amounts of $1,946,974 and $626,073, respectively,
while financing activities generated cash of $4,528,095.

Cash used in operating activities for the first nine months of 2001, which
consists of a loss for the period of $4,208,185, was partially offset by
amortization, and stock based compensation in the amounts of $241,347, and
$1,635,822, respectively. Non-cash working capital items decreased by $123,325
during the nine month period of 2001. Cash used in operating activities for
the same period in 2000 consisted of a loss of $3,716,129, which was partially
offset by amortization and non-cash compensation expenses in the amount of
$218,937, and $1,616,220 respectively. Non-cash working capital items
increased by $90,617 during the same period in 2000.

Financing activities for the first nine months of 2001 included private
placement offerings and common stock option exercises for cash totaling
$1,805,673.  Financing activities for the first nine months of 2001 also
included an increase in bank indebtedness and shareholder loans totaling
$132,167, and $67,152, respectively. Financing activities for same period in
2000 included common share subscriptions received and options exercised for
cash totaling $4,436,129, and an increase in bank indebtedness from the first
nine months of $91,966.

Investing activities during the third quarter of 2001 resulted in a net
decrease in cash of $896,022 which consisted of $759,717, net of government
grants, incurred in acquisitions and upgrades of capital assets,$113,180
incurred in deferred project costs and $23,105 increased in patent costs.
During the same period in 2000, the Company acquired capital assets net of
government grant, and technology patents in the amounts of $596,793, and
$29,280, respectively.

With the current cash on hand and management's intent to focus on the
commercial development of its BioOil technologies, the Company will require
additional financing in order to fund its continuing operations and such
commercialization during the remainder of 2001 and into the future.  The
Company continues to work closely with a global investment bank as well as its
commercialization partners with the intent of raising up to $4.5 million in
equity financing during the fourth quarter of 2001. Given market conditions
and other factors, there can be no guarantee that the Company will be
successful in securing additional financing. If adequate funds are not
available on acceptable terms when needed, the Company may be required to
delay, scale-back or eliminate the manufacturing, marketing or sales of one or
more of its products or research and development programs.


ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The Company is affected by fluctuations in foreign currencies and changes in
interest rates. The Company's revenue is primarily in US dollars while the
majority of its expenses are in Canadian currency. The Company holds cash in
both US and Canadian funds and exchanges from US currency to Canadian currency
as necessary.

The Company can be adversely affected when the Canadian currency appreciates.
The management has the ability, to some extent, to time exchanges and enter
into forward exchange contracts in an attempt to mitigate such risk. The
Company reports in US currencies. When translating the Company's financial
statements from Canadian dollars to US currencies, depending on the prevailing
exchange rate at the time, certain impact from prior exchange transactions may
be offset. The extent of the Company's exposure depends on the degree of
fluctuation in foreign currencies. Due to the nature of foreign currency
exchange, the exact exposure is difficult to estimate.

The Company holds its cash reserve in short-term deposits. The interest
revenue obtained from these instruments will depend on the market interest
rates prevailing at the time. Based on financial positions at September 30,
2001, the change in interest revenue due to changes in market interest rates
is not material. The Company also has credit facilities, which it draws upon
and repays as necessary. The interest expense depends on the prevailing market
rate at the time. At the current level of debt instruments, the Company
estimates that for every 1% adverse change in the applicable interest rate,
the Company would be exposed to a $23,000 increase in interest expenses.


PART II - OTHER INFORMATION

ITEM 2. CHANGES IN SECURITIES AND USE OF PROCEEDS

During the third quarter of 2001, the Company closed the final tranche of the
May 2001 private placement financing of equity units and raised total proceeds
of $476,375, including $395,000 in cash and $81,375 in settlement of
consulting fees payable by the Company.  Each equity unit sold for $0.80 and
consisted of one common share, no par value, of the Company and one warrant to
purchase one half of a common share.  The warrants have a two-year term,
subject to acceleration under certain circumstances, and are exercisable at a
per share price equal to $1.50. A total of 595,468 common shares and 246,875
warrants were issued to Carlos A. Grimaldi, Ricardo Altube, Jorge Kawaguchi,
Jose Luis Carrone, Cantai Property Ltd., R. Andrew Kingston and James Acheson.

On August 20, 2001, the Company closed the first tranche of a new private
placement financing of equity units for proceeds of $650,000, including
$600,000 in cash and $50,000 in settlement of consulting fees payable by the
Company.  Each equity unit sold for $0.55 and consisted of one common share,
no par value, of the Company and one warrant to purchase one half of a common
share at $0.90 for a term of six months and one warrant to purchase one half
of a common share at $1.50 for a three year term.  The warrants are subject to
acceleration under certain circumstances. A total of 1,181,818 common shares
and 772,727 warrants were issued to Chia Tai Chen, Debbie A. Boyes, Yin-Tze
Chai, Victor Tchenquiz, Cantai Property Ltd., R. Andrew Kingston and James
Acheson.

The offers and sales of securities to R. Andrew Kingston, president and chief
executive officer of the Company, and James Acheson, chief operating officer
of a subsidiary of the Company, were made to Accredited Investors as defined
under Regulation D promulgated under the Securities Act of 1933, as amended,
and are therefore exempt from United States registration requirements.  The
offers and sales of securities to all other investors in both of the private
placement financings discussed above were made to investors who were not U.S.
Persons as defined under Regulation S promulgated under the Securities Act,
and are therefore exempt from United States registration requirements.

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

(a) Exhibits

Exhibit              Description

3.1 (a)              Company Act Memorandum of DynaMotive Energy Systems
                     Corporation, as amended to date (filed as Exhibit 3.1 to
                     the Company's Quarterly Report on Form 10-QSB for the
                     quarter ended September 30, 2000, and incorporated herein
                     by reference).

3.1 (b)              Amendment to the Company Act Memorandum of DynaMotive
                     Energy Systems Corporation, dated July 3, 2001 (filed as
                     Exhibit 3.1 (b) to the Company's Quarterly Report on Form
                     10-Q for the quarter ended June 30, 2001, and
                     incorporated herein by reference).

3.2                  Articles of DynaMotive Energy Systems Corporation, as
                     amended to date (filed as Exhibit 3.2 to the Company's
                     Quarterly Report on Form 10-QSB for the quarter ended
                     September 30, 2000, and incorporated herein by
                     reference).



(b)     Reports on Form 8-K
          None.

DYNAMOTIVE ENERGY SYSTEMS CORPORATION

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized as of the 14th day of November 2001.

                               DYNAMOTIVE ENERGY SYSTEMS CORPORATION


                               /s/ Robert Andrew Kingston
                              -------------------------------------

                              Robert Andrew Kingston,

                              President & Chief Executive Officer



                              /s/ Stephen Ives
                              -------------------------------------
                              Stephen Ives
                              Chief Financial Officer